Location History:
- Milan, IT (2013)
- Torre d'Isola, IT (2007 - 2014)
Company Filing History:
2 out of 47 
1 out of 312 
1 out of 11 
Years Active: 2007-2014
Title: Martino Bolognesi: Innovator in Antiviral and Cancer Therapeutics
Introduction
Martino Bolognesi is a notable inventor based in Torre d'Isola, Italy. He has made significant contributions to the fields of antiviral and cancer therapeutics, holding a total of four patents. His work focuses on innovative solutions for treating various viral infections and cancer.
Latest Patents
Bolognesi's latest patents include groundbreaking research on Avermectins and milbemycins for the treatment, prevention, or amelioration of flavivirus infections. This patent details the use of Avermectin and milbemycin compounds, particularly ivermectin, in preparing antiviral medicaments for infections caused by viruses such as YFV (yellow fever virus), DENV (Dengue virus), JEV (Japanese encephalitis virus), TBEV (tick-borne encephalitis virus), and MODV (Modoc virus). The antiviral compositions are designed for oral administration to infected subjects or those at risk. Another significant patent involves SMAC mimetic compounds as apoptosis inducers. This invention relates to compounds that act as inhibitors of Inhibitor of Apoptosis Proteins (IAPs), which can induce apoptotic cell death, particularly beneficial in cancer treatment.
Career Highlights
Throughout his career, Martino Bolognesi has worked with prominent organizations, including Novartis Vaccines and Diagnostics and the National Research Council of Italy. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.
Collaborations
Bolognesi has collaborated with notable colleagues such as Eloise Mastrangelo and Guido Grandi. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic solutions.
Conclusion
Martino Bolognesi is a distinguished inventor whose work in antiviral and cancer therapeutics has the potential to make a significant impact on public health. His innovative patents and collaborations reflect his commitment to advancing medical science and improving treatment options for patients.